טוען...
Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient Care
Personalized cancer therapy is based on a patient’s tumor lineage, histopathology, expression analyses, and/or tumor DNA or RNA analysis. Here, we aim to develop an in vitro functional assay of a patient’s living cancer cells that could complement these approaches. We present methods for developing...
שמור ב:
| הוצא לאור ב: | Cell Rep |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Cell Press
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5745232/ https://ncbi.nlm.nih.gov/pubmed/29241554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2017.11.051 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|